Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Neuropeptide Y Y2 agonists prepared at Peptech/CRC

March 3, 1998

Bristol-Myers Squibb developing new paclitaxel derivatives

March 2, 1998

Corvas prepares new orally active antithrombotic agents

March 2, 1998

Novel antiviral agents from Lilly

March 2, 1998

Medivir studies new anticancer sterols

Feb. 27, 1998

Fujisawa develops new inhibitors of NO production

Feb. 27, 1998

Beta-lactams with dual beta-lactamase-inhibitory/antibacterial activity from Roche

Feb. 27, 1998

Schering AG reports pure antiestrogens

Feb. 27, 1998

Antimigraine agents with reduced liability for side effects developed at MS&D

Feb. 27, 1998

Orally active thrombin inhibitors prepared at C&C

Feb. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...